146 related articles for article (PubMed ID: 25455157)
1. Down-regulation of sphingosine kinase 2 (SphK2) increases the effects of all-trans-retinoic acid (ATRA) on colon cancer cells.
Chu JH; Gao ZH; Qu XJ
Biomed Pharmacother; 2014 Oct; 68(8):1089-97. PubMed ID: 25455157
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate antagonizes the effect of all-trans retinoic acid (ATRA) in a human colon cancer cell line by modulation of RARβ expression.
Sun DF; Gao ZH; Liu HP; Yuan Y; Qu XJ
Cancer Lett; 2012 Jun; 319(2):182-189. PubMed ID: 22261335
[TBL] [Abstract][Full Text] [Related]
3. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin.
Sankala HM; Hait NC; Paugh SW; Shida D; Lépine S; Elmore LW; Dent P; Milstien S; Spiegel S
Cancer Res; 2007 Nov; 67(21):10466-74. PubMed ID: 17974990
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SphK2 contributes to ATRA resistance in colon cancer through rapid degradation of cytoplasmic RXRα by K48/K63-linked polyubiquitination.
Shi WN; Cui SX; Song ZY; Wang SQ; Sun SY; Yu XF; Li Y; Zhang YH; Gao ZH; Qu XJ
Oncotarget; 2017 Jun; 8(24):39605-39617. PubMed ID: 28465486
[TBL] [Abstract][Full Text] [Related]
5. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
Schnitzer SE; Weigert A; Zhou J; Brüne B
Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
[TBL] [Abstract][Full Text] [Related]
7. [Celecoxib increased cellular ATRA sensitivity of human colon cancer cell lines through COX-2-independent mechanisms].
Liu JP; Wei HB; Zheng ZH; Guo WP; Fang JF
Yao Xue Xue Bao; 2009 Dec; 44(12):1353-8. PubMed ID: 21351468
[TBL] [Abstract][Full Text] [Related]
8. The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein.
Grbčić P; Eichmann TO; Kraljević Pavelić S; Sedić M
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639107
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells.
Kawahara S; Otsuji Y; Nakamura M; Murakami M; Murate T; Matsunaga T; Kanoh H; Seishima M; Banno Y; Hara A
Anticancer Drugs; 2013 Jun; 24(5):473-83. PubMed ID: 23426175
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of human colon cancer cells to sodium butyrate-induced apoptosis by modulation of sphingosine kinase 2 and protein kinase D.
Xiao M; Liu Y; Zou F
Exp Cell Res; 2012 Jan; 318(1):43-52. PubMed ID: 22024383
[TBL] [Abstract][Full Text] [Related]
11. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine kinase 1 is up-regulated in colon carcinogenesis.
Kawamori T; Osta W; Johnson KR; Pettus BJ; Bielawski J; Tanaka T; Wargovich MJ; Reddy BS; Hannun YA; Obeid LM; Zhou D
FASEB J; 2006 Feb; 20(2):386-8. PubMed ID: 16319132
[TBL] [Abstract][Full Text] [Related]
13. Increased SPHK2 Transcription of Human Colon Cancer Cells in Serum-Depleted Culture: The Involvement of CREB Transcription Factor.
Mizutani N; Omori Y; Tanaka K; Ito H; Takagi A; Kojima T; Nakatochi M; Ogiso H; Kawamoto Y; Nakamura M; Suzuki M; Kyogashima M; Tamiya-Koizumi K; Nozawa Y; Murate T
J Cell Biochem; 2015 Oct; 116(10):2227-38. PubMed ID: 25808826
[TBL] [Abstract][Full Text] [Related]
14. Role of down-regulated neutral ceramidase during all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuroblastoma cells.
Tanaka K; Tamiya-Koizumi K; Hagiwara K; Ito H; Takagi A; Kojima T; Suzuki M; Iwaki S; Fujii S; Nakamura M; Banno Y; Kannagi R; Tsurumi T; Kyogashima M; Murate T
J Biochem; 2012 Jun; 151(6):611-20. PubMed ID: 22451680
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of gastric cancer cells by all-trans retinoic acid through arresting cell cycle progression.
Wu Q; Chen Z; Su W
Chin Med J (Engl); 2001 Sep; 114(9):958-61. PubMed ID: 11780391
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase-2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl-1.
LeBlanc FR; Pearson JM; Tan SF; Cheon H; Xing JC; Dunton W; Feith DJ; Loughran TP
Br J Haematol; 2020 Aug; 190(3):405-417. PubMed ID: 32124438
[TBL] [Abstract][Full Text] [Related]
18. All trans retinoic acid sensitizes colon cancer cells to hyperthermia cytotoxic effects.
Callari D; Sinatra F; Paravizzini G; Libra M; Emmanuele G; Fiore B; Pezzino MF; Rasà D; Mazzarino MC; D'Alessandro N; Travali S
Int J Oncol; 2003 Jul; 23(1):181-8. PubMed ID: 12792792
[TBL] [Abstract][Full Text] [Related]
19. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA
Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid induces cell-cycle arrest in human cutaneous squamous carcinoma cells by inhibiting the mitogen-activated protein kinase-activated protein 1 pathway.
Zhang ML; Tao Y; Zhou WQ; Ma PC; Cao YP; He CD; Wei J; Li LJ
Clin Exp Dermatol; 2014 Apr; 39(3):354-60. PubMed ID: 24635079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
